nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetracycline—SLC22A11—Methotrexate—lymphatic system cancer	0.224	0.224	CbGbCtD
Tetracycline—SLC22A7—Methotrexate—lymphatic system cancer	0.213	0.213	CbGbCtD
Tetracycline—SLC22A8—Methotrexate—lymphatic system cancer	0.13	0.13	CbGbCtD
Tetracycline—SLC22A6—Methotrexate—lymphatic system cancer	0.0906	0.0906	CbGbCtD
Tetracycline—CYP3A4—Cytarabine—lymphatic system cancer	0.0843	0.0843	CbGbCtD
Tetracycline—CYP3A4—Teniposide—lymphatic system cancer	0.083	0.083	CbGbCtD
Tetracycline—ALB—Methotrexate—lymphatic system cancer	0.0772	0.0772	CbGbCtD
Tetracycline—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0581	0.0581	CbGbCtD
Tetracycline—CYP3A4—Vincristine—lymphatic system cancer	0.04	0.04	CbGbCtD
